Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Merli

Showing results (11-20 of 117) with videos related to

Pageof 12
Sort By:
Journal of Nephrology|April 17, 2026
A case of TAFRO syndrome presenting with acute kidney failure: diagnostic challenges and long-term outcomes. A lesson for the clinical nephrologistFrancesca Zanoni, Teresa Secchi, Matteo Abinti, et al.
Expert Opinion on Investigational Drugs|February 1, 2017
Siltuximab and hematologic malignancies. A focus in non Hodgkin lymphomaAndrea Ferrario, Michele Merli, Claudia Basilico, et al.
Future Oncology (London, England)|February 13, 2015
Everolimus in diffuse large B-cell lymphomasMichele Merli, Andrea Ferrario, Margherita Maffioli, et al.
Expert Opinion on Investigational Drugs|April 23, 2015
Investigational therapies targeting lymphocyte antigens for the treatment of non-Hodgkin's lymphomaMichele Merli, Andrea Ferrario, Margherita Maffioli, et al.
Frontiers in Oncology|March 3, 2023
Editorial: Epidemiological trends in hematological malignanciesMarcos de Lima, Jorge Castillo, Michele Merli, et al.
Clinical & Developmental Immunology|September 8, 2012
Indolent B-cell lymphomas associated with HCV infection: clinical and virological features and role of antiviral therapyLuca Arcaini, Michele Merli, Stefano Volpetti, et al.
Leukemia & Lymphoma|September 18, 2024
Vaccination strategies for patients with lymphoma treated in early lines of therapies: a real-world practice survey among Fondazione Italiana Linfomi centersOmbretta Annibali, Michele Merli, Carla Minoia, et al.
Hepatology (Baltimore, Md.)|April 6, 2017
Direct-acting antivirals during or after immunochemotherapy in hepatitis C virus-positive diffuse large B-cell lymphomasMichele Merli, Marco Frigeni, Manuel Gotti, et al.
Clinical and Experimental Medicine|February 14, 2020
HCV infection and non-Hodgkin lymphomas: an evolving storyIrene Defrancesco, Caterina Zerbi, Sara Rattotti, et al.
Expert Review of Hematology|July 15, 2016
New uses for brentuximab vedotin and novel antibody drug conjugates in lymphomaMichele Merli, Andrea Ferrario, Margherita Maffioli, et al.
Pageof 12

Showing results (11-20 of 117) with videos related to

Sort By:
Pageof 12
Journal of Nephrology|April 17, 2026
A case of TAFRO syndrome presenting with acute kidney failure: diagnostic challenges and long-term outcomes. A lesson for the clinical nephrologistFrancesca Zanoni, Teresa Secchi, Matteo Abinti, et al.
Expert Opinion on Investigational Drugs|February 1, 2017
Siltuximab and hematologic malignancies. A focus in non Hodgkin lymphomaAndrea Ferrario, Michele Merli, Claudia Basilico, et al.
Future Oncology (London, England)|February 13, 2015
Everolimus in diffuse large B-cell lymphomasMichele Merli, Andrea Ferrario, Margherita Maffioli, et al.
Expert Opinion on Investigational Drugs|April 23, 2015
Investigational therapies targeting lymphocyte antigens for the treatment of non-Hodgkin's lymphomaMichele Merli, Andrea Ferrario, Margherita Maffioli, et al.
Frontiers in Oncology|March 3, 2023
Editorial: Epidemiological trends in hematological malignanciesMarcos de Lima, Jorge Castillo, Michele Merli, et al.
Clinical & Developmental Immunology|September 8, 2012
Indolent B-cell lymphomas associated with HCV infection: clinical and virological features and role of antiviral therapyLuca Arcaini, Michele Merli, Stefano Volpetti, et al.
Leukemia & Lymphoma|September 18, 2024
Vaccination strategies for patients with lymphoma treated in early lines of therapies: a real-world practice survey among Fondazione Italiana Linfomi centersOmbretta Annibali, Michele Merli, Carla Minoia, et al.
Hepatology (Baltimore, Md.)|April 6, 2017
Direct-acting antivirals during or after immunochemotherapy in hepatitis C virus-positive diffuse large B-cell lymphomasMichele Merli, Marco Frigeni, Manuel Gotti, et al.
Clinical and Experimental Medicine|February 14, 2020
HCV infection and non-Hodgkin lymphomas: an evolving storyIrene Defrancesco, Caterina Zerbi, Sara Rattotti, et al.
Expert Review of Hematology|July 15, 2016
New uses for brentuximab vedotin and novel antibody drug conjugates in lymphomaMichele Merli, Andrea Ferrario, Margherita Maffioli, et al.
Pageof 12